Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00246194 · ClinicalTrials.gov registry record
Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)
A clinical trial, sponsored by Janssen.
- Completed
- Registry status
- 532
- Enrollment target
NCT00246194: Completed study, sponsored by Janssen.
NCT00246194 is a clinical trial that has completed, run by Janssen. The registered enrollment target is 532 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00246194 has completed, sponsored by Janssen.
- COMPLETED
- Registry status
- 532 participants
- Enrollment target
Study Summary
The purpose of this study is to examine treatment practices of adult schizophrenia patients by their own doctors, and to assess patient outcomes when treated with long-acting risperidone injection over a two-year period of observation.
Primary Outcome
The CGI-S is a 7-point scale ranging from 1 to 7 (normal, not at all ill to among the most severely ill patients), which measures disease severity in psychiatric patients. The scale is completed by physician.
Interventions
- DRUG risperidone (RISPERDAL CONSTA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 532 participants |
| Start Date | 2004-09 |
| Est. Completion | 2007-11 |
What the finished NCT00246194 record still lists
NCT00246194 is an observational study that tracks outcomes without assigning an intervention. The registered 532 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which risperidone (RISPERDAL CONSTA) is the first listed.
NCT00246194 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00246194 about?
NCT00246194 is a clinical study titled "Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)". The purpose of this study is to examine treatment practices of adult schizophrenia patients by their own doctors, and to assess patient outcomes when treated with long-acting risperidone injection over a two-year period of observation.
What is the current status of trial NCT00246194?
This trial is currently completed. The enrollment target is 532 participants. The study started on 2004-09. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00246194?
The interventions under investigation include: risperidone (RISPERDAL CONSTA) (DRUG).
Who is sponsoring clinical trial NCT00246194?
This trial is sponsored by Janssen, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05793151 · 532 participants · NA
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
- NCT06378866 · 532 participants · Phase 2
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
- NCT07219173 · 531 participants · Phase 2
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- NCT04910685 · 534 participants · Phase 2
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia